New Serosal Lined Antireflux Ureteroileal Implantation Technique On A GIA Stapler Detubularized Ileal Neobladder Reviewed
Friday, 18 November 2005
BERKELEY, CA (UroToday.com) - The importance of an antireflux ureteral reimplantation after orthotopic bladder replacement is a much debated question.
read more
|
Health Briefs for Everyone / Bladder Cancer: New Tool for Early Detection
Friday, 11 November 2005
Matritech, Inc., the maker of the NMP22® BladderChek® test, is dedicated to providing medical professionals with the resources to increase bladder cancer awareness.
read more
|
Bladder Cancer Awareness ? Early Detection Saves Lives
Friday, 11 November 2005
According to the National Cancer Institute, the prevalence of bladder cancer in the U.S. has surpassed that of lung cancer.
read more
|
Age And Comorbiditity Impact Surgical Therapy In Older Bladder Carcinoma Patients. A Population Based Study
Thursday, 10 November 2005
BERKELEY, CA (UroToday.com) - Recent population based studies suggest that the academic principles for treating muscle invasive bladder cancer may not be regularly applied in the general population.
read more
|
Multicenter Study Reports On ImmunoCyt Urine Test To Detect Bladder Cancer
Friday, 04 November 2005
BERKELEY, CA (UroToday.com) - The natural history of transitional cell carcinoma of the bladder includes tumor recurrence and progression in up to 70% and 25%, respectively.
read more
|
Older Patients Less Likely To Get Best Care For Invasive Bladder Cancer
Friday, 04 November 2005
NEW YORK (Reuters Health) - A new population-based study has found patients 75 or older with invasive bladder cancer are less likely to receive the recommended surgical treatment for the disease, even after comorbidity is taken into account.
read more
|
BJUI Mini Reviews - Intravesical Gemcitabine for Superficial Bladder Cancer: Rationale for a New Treatment Option
Tuesday, 01 November 2005
The present overview
will address the rationale and the initial
results of intravesical gemcitabine as a novel
chemotherapeutic agent for SBC.
Login to read more...
|
Urinary Telomerase An Accurate Test For Bladder Cancer
Thursday, 27 October 2005
NEW YORK (Reuters Health) - Urinary telomerase levels, determined by a telomeric repeat amplification protocol (TRAP)
assay, is a sensitive and specific marker of bladder tumors, even those of low grade, Italian investigators report in
the October 26th issue of the Journal of the American Medical Association.
read more
|
Approach To Urologic Malignancies In Solid Organ Transplant Patients
Friday, 21 October 2005
BERKELEY, CA (UroToday.com) - Patients with solid organ transplants are at risk for tumor development in their native as well as transplanted organs.
read more
|
Osteopontin Levels Predict Disease Stage In Bladder Transitional Cell Carcinoma
Tuesday, 18 October 2005
NEW YORK (Reuters Health) - Plasma osteopontin levels increase with tumor stage in patients with transitional cell carcinoma (TCC) of the bladder, according to a report in the October issue of BJU International.
read more
|
BJUI Mini Reviews - The Role of Repeat Transurethral Resection in the Management of High-Risk Superficial Transitional Cell Bladder Cancer
Saturday, 01 October 2005
Therefore, for the purpose of this review we have excluded the latter group.
Login to read more...
|
BJUI Mini Reviews - Terence Millin: Pioneer of the Retropubic Space
Saturday, 01 October 2005
Terence Millin was, without doubt, Ireland’s
most famous urologist and was responsible
for markedly changing the approach to the
surgery of the prostate gland.
Login to read more...
|
BJUI Mini Reviews - Is Intravesical Chemotherapy for Superficial Bladder Cancer Still Justified?
Saturday, 01 October 2005
These findings review the intravesical therapy in superficial bladder
cancer, assessing first the widely accepted
data before examining the important
comparative trials of chemotherapy and
administration of BCG.
Login to read more...
|
Phase I Data On Antisense Oligonucleotide To Clusterin Reported
Thursday, 22 September 2005
BERKELEY, CA (UroToday Inc.) - Clusterin is a cytoprotective chaperone protein that promotes cell survival and confers resistance to treatments.
read more
|
Urologists Should Play Integral Role In Palliative Care Of Patients
Tuesday, 20 September 2005
BERKELEY, CA (UroToday Inc.) - Genitourinary cancer accounted for 21% of all new cancer cases in 2003 and resulted in 16% of cancer deaths.
read more
|
Second Cancers Following Radiotherapy For Rectal Cancer
Monday, 19 September 2005
BERKELEY, CA (UroToday Inc.) - This study by Birgisson et al. out of the Karolinska Institute in Sweden sought to analyze the occurrence of secondary cancers in patients with rectal cancer treated with external beam radiotherapy.
read more
|
ESWL For Bladder Calculi Without Associated Prostate Surgery Reviewed In Recent Study
Friday, 16 September 2005
BERKELEY, CA (UroToday Inc.) - In the past, the standard management of bladder lithiasis consisted of surgical removal of the stone plus de-obstructive prostate surgery, because the etiology of bladder lithiasis was thought to be the existence of bladder outlet obstruction (BOO).
read more
|
Cystectomy Safer In High-Volume Hospitals
Monday, 12 September 2005
NEW YORK (Reuters Health) - Hospitals that perform a high number of cystectomies have significantly fewer patient complication and fatality rates than do those with a low volume of such procedures, according US researchers, who also found that staffing affects patient outcomes.
read more
|
p53 Immunodetection In Urine Samples Successful And Predictive Of Bladder Tumor Progression
Wednesday, 07 September 2005
BERKELEY, CA (UroToday Inc.) - p53 is a tumor suppressor gene located on chromosome 17p. It is mutated in 50% of human cancers.
read more
|
BJUI Mini Reviews - Microsatellite Instability and Transitional Cell Carcinoma of the Upper Urinary Tract
Thursday, 01 September 2005
This article, reviews the current and future uses of MSI for
following UUT-TCC.
Login to read more...
|
Fluorescent Imaging Helps Spot Bladder Cancer
Wednesday, 31 August 2005
NEW YORK (Reuters Health) - Hexaminolevulinate (HAL) fluorescence cystoscopy is more effective than the standard white light approach in detecting bladder cancer, German and Dutch researchers report in the September issue of the Journal of Urology.
read more
|
The Effect Of Obesity In The Incidence Of Prostate, Bladder, And Renal Cancer In Men
Friday, 19 August 2005
BERKELEY, CA (UroToday Inc.) - Obesity has been associated with an increased risk of prostate and renal cancer. The majority of these epidemiological studies have been performed in Europe and in the United States.
read more
|
Survivin Levels Highly Specific For Bladder Cancer
Tuesday, 02 August 2005
NEW YORK (Reuters Health) - Survivin expression in urine and tumor tissue is highly specific for transitional cell carcinoma (TCC) of the bladder, according to a report in the August issue of the International Journal of Cancer.
read more
|
Angiogenin Identified As A Biomarker For Bladder Cancer Risk
Thursday, 14 July 2005
NEW YORK (Reuters Health) - Plasma levels of angiogenin, a potent angiogenic polypeptide, are higher than normal in patients with bladder carcinoma and those with recurrence of superficial bladder cancer, researchers report.
read more
|
Full-Genome Expression Analysis In Superficial Bladder Cancer Predicts For Disease Progression
Thursday, 07 July 2005
BERKELEY, CA (UroToday Inc.) - Most bladder tumors are superficial but often recur following treatment. In 20-50% of cases, the recurrent tumors will progress to a higher stage, with a substantially worse long-term prognosis.
read more
|
Gene Expression Classifiers Separate Bladder Tumors by Stage, Histologic Type and Outcome
Wednesday, 06 July 2005
BERKELEY, CA (UroToday Inc.) - In an attempt to better determine the natural history of bladder cancers, researchers have investigated individual protein expression and gene alterations.
read more
|
Mitomycin C Plus Photodynamic Therapy Promising In Recurrent Bladder Cancer
Tuesday, 05 July 2005
NEW YORK (Reuters Health) - Instillation of mitomycin C followed by 5-aminolaevulinic acid-mediated photodynamic therapy (ALA-PDT) is safe and well tolerated, "with potential for managing difficult-to-control" superficial carcinoma of the bladder, results of a phase I study indicate.
read more
|
BJUI Mini Reviews - Molecular Staging of Bladder Cancer
Friday, 01 July 2005
That study indicated the need to incorporate
objective staging methods using molecular
markers specific to UC to complement the
morphological approach, and devise a refined
system of staging that focuses on the
biological behaviour of the tumour and its
predicted clinical outcome, thereby equipping
the clinician with a better insight on the
appropriate treatment regimen to be
instituted.
Login to read more...
|
BJUI Mini Reviews - The Role of Photodynamic Diagnosis in the Contemporary Management of Superficial Bladder Cancer
Friday, 01 July 2005
This review will attempt to clarify, using the evidence available, where exactly PDD fits into the options available to contemporary urologists.
Login to read more...
|
Mistletoe Extract May Be Alternative Bladder Cancer Therapy
Thursday, 30 June 2005
NEW YORK (Reuters Health) - Extract of European mistletoe (Viscum album L.) appears to be as effective as bacillus Calmette-Guerin (BCG) as adjuvant intravesical treatment of superficial bladder cancer, German researchers report in the July issue of the Journal of Urology.
read more
|
MassARRAY Technology Provides Sensitive Detection of Human Papillomavirus in Schistosomiasis-Associated Bladder Cancer
Thursday, 23 June 2005
BERKELEY, CA (UroToday Inc.) - Human papillomavirus (HPV) is associated with schistosomiasis-associated bladder cancer, cervical cancer and head and neck cancers. Nearly 50% of schistosomiasis-associated bladder cancer has HPV DNA by in situ hybridization.
read more
|
Molecular Signature Predicts Outcome In Superficial Bladder Cancer
Tuesday, 21 June 2005
BERKELEY, CA (UroToday Inc.) - Despite the efficacy of intravesical BCG for superficial bladder cancer, as many as 50% of patients with high grade T1 tumors may recur.
read more
|
Thirty Percent of Patients with Negative Pelvic Lymph Nodes After Cystectomy May Harbor Micrometastasis by RT-PCR
Thursday, 16 June 2005
BERKELEY, CA (UroToday Inc.) - In the May issue of Clinical Cancer Research, Kurahashi and colleagues from Kobe University evaluated the efficacy of RT-PCR in detecting occult micrometastasis after radical cystectomy.
read more
|
Cisplatin-based Chemoradiation for Bladder Cancer: FGFR and ERB-2 Expression Predict Treatment Response
Monday, 13 June 2005
BERKELEY, CA (UroToday Inc.) - While radical cystectomy remains the standard of care for muscle invasive bladder cancer in the United States, well-selected patients who are not candidates for surgery may be treated with chemoradiation with satisfactory results.
read more
|
HER2 Expression Elevated with Bladder Cancer
Wednesday, 01 June 2005
NEW YORK (Reuters Health) - High HER2 expression is seen with primary bladder cancer and with metastatic disease, suggesting that HER2-targeted therapy could be a useful approach for this malignancy, according to a new report by investigators in Sweden.
read more
|
Hair Dye Does Not Raise Risk of Bladder or Breast Cancer
Tuesday, 24 May 2005
NEW YORK (Reuters Health) - A meta-analysis of published studies failed to find strong evidence of an increased risk of breast or bladder cancer among individuals who dye their hair, investigators report in the Journal of the American Medical Association for May 25th.
read more
|
AUA Scientific News Brief - Bladder Cancer Clinical Findings
Monday, 23 May 2005
San Antonio, TX, Urologist Giora Katz, M.D., presented findings in conjunction with Dr. Edward Messing from University of Rochester Medical Center.
read more
|
Bladder Tumor Gene Expression Profiling Predicts Response to Neoadjuvant MVAC Chemotherapy Before Cystectomy
Friday, 20 May 2005
BERKELEY, CA (UroToday Inc.) - The use of neoadjuvant chemotherapy for muscle invasive bladder cancer has been shown to result in an improvement in survival in selected patients treated with radical cystectomy (SWOG-8710; N Engl J Med. 2003 Aug 28;349(9):859-66).
read more
|
'Death from cancer' Gene Signature Predicts Poor Outcome
Tuesday, 19 April 2005
ANAHEIM, California (Reuters Health) - Using microarray analysis, cancer researchers have identified an 11-gene signature that is strongly associated with a poor response to treatment, increased risk of metastatic spread, and shortened survival in patients with a variety of primary tumor types.
read more
|
In Randomized Study of Patients with Localized Cancer and DVT, Low Molecular Weight Heparin found to offer Survival Advantage over Coumarin Derivatives
Friday, 15 April 2005
BERKELEY, CA (UroToday Inc.) - Without question, patients with cancer at a higher risk for thromboembolic events. Until very recently, the decision to place a patient with deep vein thrombosis (DVT) on coumarin or low molecular weight heparin was largely based on drug cost or patient convenience.
read more
|
Extracapsular Extension of Pelvic Lymph Node Metastases From Urothelial Carcinoma of the Bladder Is an Independent Prognostic Factor
Wednesday, 13 April 2005
BERKELEY, CA (UroToday Inc.) - Recent data from the invasive bladder cancer literature showed that pathologic information obtained from the pelvic lymphadenectomy may be very useful for segregating patients based on risk.
read more
|
Microscopic Hematuria Not Likely to Affect Pregnancy Outcome
Tuesday, 12 April 2005
NEW YORK (Reuters Health) - Pregnant women with dipstick-positive hematuria can be reassured that their pregnancy is unlikely to be affected by the condition, Australian researchers advise.
read more
|
Paclitaxel with Gemcitabine in Advanced Urothelial Transitional Cell Carcinoma
Tuesday, 05 April 2005
BERKELEY, CA (UroToday Inc.) - In the United States urothelial carcinoma is primarily of transitional cell (TCC) histology.
read more
|
BJUI Mini Reviews - Molecular Prognostic Factors in Bladder Cancer
Friday, 01 April 2005
Herein this article summarizes recent publications on
some of the more promising molecular
markers for prognostication in bladder cancer
and comment on potential clinical
applications.
Login to read more...
|
Study Examines Outcomes and Cost of Two Surgeons versus Single-Surgeon Cystectomy with Urinary Diversion
Tuesday, 29 March 2005
BERKELEY, CA (UroToday Inc.) - Bladder cancer is known to be one of the most expensive cancers in terms of healthcare expense from the time of diagnosis to death.
read more
|
Prostatic Stromal Invasion by Bladder Cancer (TCC): When is Safe to Perform an Orthotopic Neobladder?
Friday, 25 March 2005
BERKELEY, CA (UroToday Inc.) - Although the incidence of urethral recurrence in classic radical cystectomy series has been reported to be as high as 10%, the advent of the orthotopic continent urinary diversion has indirectly decreased the indications for urethrectomy.
read more
|
Promoter Hypermethylation Predicts Tumor Stage and Progression in Transitional Cell Carcinoma
Wednesday, 23 March 2005
BERKELEY, CA (UroToday Inc.) - In the last several years, an emphasis on genomic tumor analysis has led to the discovery of potential markers of tumor aggressiveness and progression.
read more
|
Genetic Polymorphisms Associated with Tumor Recurrence in Superficial Bladder Cancer
Monday, 14 March 2005
BERKELEY, CA (UroToday Inc.) - Although the treatment of superficial bladder cancer has been revolutionized by the introduction of intravesical BCG, approximately 20 to 30% of BCG-treated patients may develop treatment refractory recurrences.
read more
|
Urinary Fibronectin Could Help Spot Bladder Cancer
Friday, 11 March 2005
NEW YORK (Reuters Health) - Measuring urinary levels of fibronectin may to be helpful in diagnosing bladder cancer, according to Spanish researchers.
read more
|
BJUI Mini Reviews - Molecular Pathways in Bladder Cancer: Part 1
Tuesday, 01 March 2005
In this two-part review based on these six categories, we
define the molecular pathways of bladder
transitional cell carcinogenesis.
Login to read more...
|
Bladder Cancer 
